Evidence map›Paper›PMID 41566134›Full record

Observational studyThe Journal of international medical research2026

Association between uric acid-to-albumin ratio and clinical outcomes in patients with hypertrophic cardiomyopathy: A retrospective observational study.

Ayşegül Ülgen Kunak, Tolga Kunak

Abstract readObservational Study
In one paragraph

Observational study in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ayşegül Ülgen KunakMinistry of Health Antalya Training and Research Hospital, Cardiology, Türkiye.ORCID 0000-0002-8930-3651
Tolga KunakAkdeniz University Faculty of Medicine, Cardiology, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ObjectiveTo evaluate the association between the uric acid-to-albumin ratio and adverse clinical outcomes in patients with hypertrophic cardiomyopathy.MethodsThis retrospective, observational single-center study included 124 patients with hypertrophic cardiomyopathy (58 with obstructive and 66 with nonobstructive hypertrophic cardiomyopathy) and 60 age- and sex-matched healthy controls. Baseline clinical, laboratory, and echocardiographic parameters were analyzed. A composite endpoint comprising cardiovascular death, heart failure hospitalization, and appropriate implantable cardioverter-defibrillator shocks was assessed. Logistic regression analyses were used to identify independent associations, and receiver operating characteristic analysis was performed to evaluate discriminative ability.ResultsThe uric acid-to-albumin ratio was higher in patients with obstructive hypertrophic cardiomyopathy than in those with nonobstructive hypertrophic cardiomyopathy and controls (1.56 ± 0.15 vs 1.21 ± 0.08 vs 1.15 ± 0.11;

Indexed as

Cardiomyopathy, HypertrophicSerum AlbuminUric AcidAdultAgedBiomarkersCase-Control StudiesEchocardiographyFemaleHumansMaleMiddle AgedPrognosisRetrospective StudiesROC CurveBiomarkersSerum AlbuminUric AcidbiomarkerHypertrophic cardiomyopathyprognosisrisk stratificationuric acid-to-albumin ratio

Identifiers

PMID41566134
PMCPMC12833106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.